Form 13-F position report

* RESMED INC

Reported by CHARLES SCHWAB INVESTMENT MANAGEMENT INC

RMD CUSIP 761152107 Manager CIK 0000884546

Reported 765,828 shares, up 11,470 (1.5%) from the prior quarter.

Reported value -12.2%; share count 1.5% vs. the prior quarter.

Added
% of reported 13F value 0.06% This manager · Q2 2022
Shares 765,828 Quarter-end amount reported
Reported value $160,541,000 Fair value at quarter end
Consecutive quarters held 37 Through Q2 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 194129000
2021-12-31 195579000
2022-03-31 182940000
2022-06-30 160541000
2022-09-30 169236000
2022-12-31 164065341
2023-03-31 175756556
2023-06-30 177923239
2023-09-30 120835816
2023-12-31 148502974
2024-03-31 177860050
2024-06-30 174204068
2024-09-30 225578413
2024-12-31 218860904
2025-03-31 223430953
2025-06-30 263418258
2025-09-30 292245918
2025-12-31 265790169
2026-03-31 254851920
2026-06-30 238235538

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * RESMED INC held by CHARLES SCHWAB INVESTMENT MANAGEMENT INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Added 1,222,473 +87,174 (7.7%) 0.03% $238,235,538 2026-08-14
Q1 2026 Added 1,135,299 +31,840 (2.9%) 0.04% $254,851,920 2026-05-15
Q4 2025 Added 1,103,459 +35,816 (3.4%) 0.04% $265,790,169 2026-02-13
Q3 2025 Added 1,067,643 +46,642 (4.6%) 0.05% $292,245,918 2025-11-10
Q2 2025 Added 1,021,001 +22,873 (2.3%) 0.05% $263,418,258 2025-08-12
Q1 2025 Added 998,128 +41,108 (4.3%) 0.04% $223,430,953 2025-05-09
Q4 2024 Added 957,020 +32,973 (3.6%) 0.04% $218,860,904 2025-02-06
Q3 2024 Added 924,047 +13,985 (1.5%) 0.04% $225,578,413 2024-11-12
Q2 2024 Added 910,062 +11,915 (1.3%) 0.03% $174,204,068 2024-08-12
Q1 2024 Added 898,147 +34,858 (4.0%) 0.04% $177,860,050 2024-05-09
Q4 2023 Added 863,289 +46,113 (5.6%) 0.04% $148,502,974 2024-02-06
Q3 2023 Added 817,176 +2,882 (0.4%) 0.03% $120,835,816 2023-11-08
Q2 2023 Added 814,294 +11,716 (1.5%) 0.05% $177,923,239 2023-08-10
Q1 2023 Added 802,578 +14,295 (1.8%) 0.05% $175,756,556 2023-05-12
Q4 2022 Added 788,283 +13,038 (1.7%) 0.05% $164,065,341 2023-02-13
Q3 2022 Added 775,245 +9,417 (1.2%) 0.06% $169,236,000 2022-11-14
Q2 2022 Added 765,828 +11,470 (1.5%) 0.06% $160,541,000 2022-08-15
Q1 2022 Added 754,358 +3,521 (0.5%) 0.05% $182,940,000 2022-05-13
Q4 2021 Added 750,837 +14,247 (1.9%) 0.06% $195,579,000 2022-02-11
Q3 2021 Reduced 736,590 -21,029 (-2.8%) 0.06% $194,129,000 2021-11-16
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

722 managers reported * RESMED INC for Q2 2022.

Managers reporting * RESMED INC in Q2 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 16,062,039 +194,582 0.09% $3,367,084,000 37 qtrs
BlackRock Inc Reduced 13,337,125 -22,590 0.09% $2,795,861,000 37 qtrs
FMR LLC Added 7,519,621 +535,739 0.16% $1,576,338,000 37 qtrs
WCM INVESTMENT MANAGEMENT LLC Reduced 6,416,199 -2,197,393 4.9% $1,366,073,000 15 qtrs
STATE STREET CORPORATION Reduced 6,425,491 -65,486 0.08% $1,346,976,000 37 qtrs
Capital World Investors Added 4,487,021 +16,023 0.2% $940,614,000 27 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 2,984,074 +62,715 0.09% $624,494,000 37 qtrs
NORTHERN TRUST CORPORATION Reduced 2,026,949 -145,912 0.09% $424,910,000 37 qtrs
Invesco Ltd Reduced 1,654,615 -96,700 0.11% $346,859,000 37 qtrs
Ownership Capital B V Added 1,602,034 +57,780 5.77% $335,834,000 6 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2022
Filed
August 15, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
765,828
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.